SHSE:688166 (China)
Â
Class A
Â¥
35.23
-0.89 (-2.46%)
Sep 11
Business Description
Brightgene Bio-medical Technology Co Ltd
ISIN : CNE100003PR1
Share Class Description:
SHSE:688166: Class ATotal Employee Number:
1,196Compare
Compare
Traded in other countries / regions
688166.China Index Membership
SSE Composite IndexCSI 500 Index IPO Date
2019-11-08Description
Brightgene Bio-medical Technology Co Ltd is engaged in the Research and development and production of pharmaceutical intermediates, active pharmaceutical ingredients and formulations with high technological barriers.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.52 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.85 | |||||
Debt-to-EBITDA | 17.01 | |||||
Interest Coverage | 2.88 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.74 | |||||
Beneish M-Score | -2.08 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.8 | |||||
3-Year EBITDA Growth Rate | -9.7 | |||||
3-Year EPS without NRI Growth Rate | -51.3 | |||||
3-Year FCF Growth Rate | 32.7 | |||||
3-Year Book Growth Rate | 4.7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 55.25 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.25 | |||||
9-Day RSI | 44.33 | |||||
14-Day RSI | 46.23 | |||||
3-1 Month Momentum % | -10.2 | |||||
6-1 Month Momentum % | -5.92 | |||||
12-1 Month Momentum % | -56.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.25 | |||||
Quick Ratio | 1.91 | |||||
Cash Ratio | 1.37 | |||||
Days Inventory | 208.55 | |||||
Days Sales Outstanding | 90.69 | |||||
Days Payable | 98.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.05 | |||||
Dividend Payout Ratio | 0.06 | |||||
3-Year Dividend Growth Rate | -7.2 | |||||
Forward Dividend Yield % | 0.05 | |||||
5-Year Yield-on-Cost % | 0.06 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -2.27 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 53.88 | |||||
Operating Margin % | 15.33 | |||||
Net Margin % | 7.06 | |||||
EBITDA Margin % | 11.18 | |||||
FCF Margin % | -1.12 | |||||
OCF Margin % | 16.62 | |||||
ROE % | 3.7 | |||||
ROA % | 1.63 | |||||
ROIC % | 4.23 | |||||
3-Year ROIIC % | -6.61 | |||||
ROC (Joel Greenblatt) % | 4.6 | |||||
ROCE % | 3.17 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 153.17 | |||||
Forward PE Ratio | 34.2 | |||||
PE Ratio without NRI | 121.48 | |||||
Shiller PE Ratio | 101.94 | |||||
PEG Ratio | 202.47 | |||||
PS Ratio | 10.64 | |||||
PB Ratio | 5.03 | |||||
Price-to-Tangible-Book | 5.92 | |||||
Price-to-Free-Cash-Flow | 3523 | |||||
Price-to-Operating-Cash-Flow | 58.91 | |||||
EV-to-EBIT | 111.35 | |||||
EV-to-EBITDA | 111.35 | |||||
EV-to-Revenue | 12.45 | |||||
EV-to-FCF | -1106.5 | |||||
Price-to-GF-Value | 0.83 | |||||
Price-to-Graham-Number | 5.65 | |||||
Earnings Yield (Greenblatt) % | 0.9 | |||||
FCF Yield % | -0.1 | |||||
Forward Rate of Return (Yacktman) % | -22.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Brightgene Bio-medical Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,364.298 | ||
| EPS (TTM) (Â¥) | 0.23 | ||
| Beta | 1.7633 | ||
| 3-Year Sharpe Ratio | 0.56 | ||
| 3-Year Sortino Ratio | 1.11 | ||
| Volatility % | 62.62 | ||
| 14-Day RSI | 46.23 | ||
| 14-Day ATR (Â¥) | 2.035785 | ||
| 20-Day SMA (Â¥) | 36.294 | ||
| 12-1 Month Momentum % | -56.61 | ||
| 52-Week Range (Â¥) | 28.74 - 102.74 | ||
| Shares Outstanding (Mil) | 435.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Brightgene Bio-medical Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Brightgene Bio-medical Technology Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.016000 Cash Dividend | 2026-06-09 | 44.00 (-3.38%) | ||
| CNY 0.096000 Cash Dividend | 2025-06-23 | 58.57 (+2.48%) |
Show
Entries
Brightgene Bio-medical Technology Co Ltd Frequently Asked Questions
What is Brightgene Bio-medical Technology Co Ltd(SHSE:688166)'s stock price today?
The current price of SHSE:688166 is ¥35.23. The 52 week high of SHSE:688166 is ¥102.74 and 52 week low is ¥28.74.
When is next earnings date of Brightgene Bio-medical Technology Co Ltd(SHSE:688166)?
The next earnings date of Brightgene Bio-medical Technology Co Ltd(SHSE:688166) is .
Does Brightgene Bio-medical Technology Co Ltd(SHSE:688166) pay dividends? If so, how much?
The Dividend Yield %  of Brightgene Bio-medical Technology Co Ltd(SHSE:688166) is 0.05% (As of Today), Highest Dividend Payout Ratio of Brightgene Bio-medical Technology Co Ltd(SHSE:688166) was 1.6. The lowest was 0.06. And the median was 0.23. The  Forward Dividend Yield % of Brightgene Bio-medical Technology Co Ltd(SHSE:688166) is 0.05%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers